PortfoliosLab logoPortfoliosLab logo
TUSK vs. MED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TUSK vs. MED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mammoth Energy Services, Inc. (TUSK) and Medifast, Inc. (MED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TUSK achieves a 64.86% return, which is significantly higher than MED's -3.00% return.


TUSK

1D
-0.33%
1M
-6.15%
YTD
64.86%
6M
63.98%
1Y
1.33%
3Y*
-13.36%
5Y*
-7.44%
10Y*

MED

1D
-2.45%
1M
-17.71%
YTD
-3.00%
6M
-8.16%
1Y
-24.38%
3Y*
-50.39%
5Y*
-46.93%
10Y*
-8.36%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TUSK vs. MED - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TUSK
Mammoth Energy Services, Inc.
64.86%-38.33%-32.74%-48.44%375.27%-59.10%102.27%-87.59%-7.67%29.14%
MED
Medifast, Inc.
-3.00%-39.39%-73.79%-38.34%-42.31%9.36%86.18%-9.73%82.11%72.33%

Correlation

The correlation between TUSK and MED is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Oct 14, 2016

0.18

Fundamentals

Market Cap

TUSK:

$147.41M

MED:

$114.02M

EPS

TUSK:

-$1.47

MED:

-$1.82

PS Ratio

TUSK:

2.35

MED:

0.33

PB Ratio

TUSK:

0.56

MED:

0.58

Total Revenue (TTM)

TUSK:

$62.70M

MED:

$346.10M

Gross Profit (TTM)

TUSK:

$9.65M

MED:

$242.70M

EBITDA (TTM)

TUSK:

-$14.10M

MED:

-$3.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TUSK vs. MED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TUSK
TUSK Risk / Return Rank: 4444
Overall Rank
TUSK Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
TUSK Sortino Ratio Rank: 4545
Sortino Ratio Rank
TUSK Omega Ratio Rank: 4444
Omega Ratio Rank
TUSK Calmar Ratio Rank: 4444
Calmar Ratio Rank
TUSK Martin Ratio Rank: 4343
Martin Ratio Rank

MED
MED Risk / Return Rank: 1818
Overall Rank
MED Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
MED Sortino Ratio Rank: 1616
Sortino Ratio Rank
MED Omega Ratio Rank: 1818
Omega Ratio Rank
MED Calmar Ratio Rank: 1818
Calmar Ratio Rank
MED Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TUSK vs. MED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mammoth Energy Services, Inc. (TUSK) and Medifast, Inc. (MED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TUSKMEDDifference
Sharpe ratioReturn per unit of total volatility

+0.61

Sortino ratioReturn per unit of downside risk

+1.33

Omega ratioGain probability vs. loss probability

1.07

0.91

+0.15

Calmar ratioReturn relative to maximum drawdown

0.03

-0.65

+0.69

Martin ratioReturn relative to average drawdown

0.06

-1.10

+1.16

TUSK vs. MED - Sharpe Ratio Comparison

The current TUSK Sharpe Ratio is 0.02, which is higher than the MED Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of TUSK and MED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TUSK vs. MED - Drawdown Comparison

The maximum TUSK drawdown since its inception was -98.55%, roughly equal to the maximum MED drawdown of -98.40%. Use the drawdown chart below to compare losses from any high point for TUSK and MED.


Loading charts...

Drawdown Indicators


TUSKMEDDifference

Max Drawdown

Largest peak-to-trough decline

-98.55%

-98.40%

-0.15%

Max Drawdown (1Y)

Largest decline over 1 year

-40.75%

-37.39%

-3.36%

Max Drawdown (3Y)

Largest decline over 3 years

-69.27%

-90.91%

+21.64%

Max Drawdown (5Y)

Largest decline over 5 years

-80.00%

-96.29%

+16.29%

Max Drawdown (10Y)

Largest decline over 10 years

-96.76%

Current Drawdown

Current decline from peak

-92.37%

-96.48%

+4.11%

Average Drawdown

Average peak-to-trough decline

-73.08%

-50.88%

-22.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.94%

22.29%

+1.65%

Volatility

TUSK vs. MED - Volatility Comparison

Mammoth Energy Services, Inc. (TUSK) has a higher volatility of 22.11% compared to Medifast, Inc. (MED) at 10.90%. This indicates that TUSK's price experiences larger fluctuations and is considered to be riskier than MED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TUSKMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.11%

10.90%

+11.21%

Volatility (6M)

Calculated over the trailing 6-month period

54.70%

32.00%

+22.70%

Volatility (1Y)

Calculated over the trailing 1-year period

67.06%

41.57%

+25.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.65%

45.29%

+27.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

87.15%

47.74%

+39.41%

Dividends

TUSK vs. MED - Dividend Comparison

Neither TUSK nor MED has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
MED
Medifast, Inc.
0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%
TUSK
Mammoth Energy Services, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%11.36%1.39%0.00%0.00%0.00%

Financials

TUSK vs. MED - Financials Comparison

This section allows you to compare key financial metrics between Mammoth Energy Services, Inc. and Medifast, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20222023202420252026
22.03M
76.04M
(TUSK) Total Revenue
(MED) Total Revenue
Values in USD except per share items

TUSK vs. MED - Profitability Comparison

The chart below illustrates the profitability comparison between Mammoth Energy Services, Inc. and Medifast, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-40.0%-20.0%0.0%20.0%40.0%60.0%80.0%20222023202420252026
71.6%
68.1%
Portfolio components
TUSK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mammoth Energy Services, Inc. reported a gross profit of 15.78M and revenue of 22.03M. Therefore, the gross margin over that period was 71.6%.

MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.

TUSK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mammoth Energy Services, Inc. reported an operating income of 4.68M and revenue of 22.03M, resulting in an operating margin of 21.3%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.

TUSK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mammoth Energy Services, Inc. reported a net income of 5.19M and revenue of 22.03M, resulting in a net margin of 23.6%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.


Frequently Asked Questions


TUSK and MED have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TUSK has higher volatility (22.11%) compared to MED (10.90%). In terms of maximum drawdown, TUSK dropped -98.55% vs MED's -98.40%.

TUSK currently has the higher Sharpe Ratio (0.02 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TUSK and MED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer